![7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3](https://www.ruifuchemical.com/uploads/7-Chloro-1234-tetrahydrobenzobazepin-5-one-CAS-160129-45-3.jpg)
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3
Manufacturer Supple, Quality, Commercial Productio
Tolvaptan et intermedia:
Tolvaptan CAS 150683-30-0
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3
o-Toluoyl Chloride CAS 933-88-0
4-Amino-2-Methylbenzoic Acidum CAS 2486-75-1
2-Methyl-4-Acidum Nitrobenzoicum CAS 1975-51-5
| Nomen chemicum | 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one |
| Synonyma | 7-Chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-unum;7-Chloro-3,4-dihydro-1H-benzo[b]azepin-5(2H)-one |
| CAS Number | 160129-45-3 |
| CATTUS Number | RF-PI395 |
| Stock Status | In Stock, Productio Ascendite ad Tons |
| Formulae hypotheticae | C10H10ClNO |
| M. Pondus | 195.65 |
| Liquescens punctum | 103.0 ad 107.0℃ |
| Solubilitas | Solutum in Methanol |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Lux viridis est lux Yellow pulveris |
| Lepidium sativum Methodi | NMR, HPLC |
| Puritas / Analysis Methodus | ≥99.0% (HPLC) |
| Damnum in Siccatio | ≤1.0% |
| Residere in Ignition | ≤0.50% |
| Unam immunditiam | ≤0.50% |
| Totalis immunditias | ≤1.0% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Intermedia Tolvaptan (CAS 150683-30-0), tractatus de Hyponatremia |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-unum (CAS 160129-45-3) medium est in synthesi Tolvaptan (CAS 150683-30-0).Tolvaptan arginine vasopressin V2 receptor contrarius cum IC50 1.28µM electivum, competitive ore activum nonpeptidum cum inhibitione aggregationis laminae inductae.Tolvaptan tractat hyponatremiam cum defectu cordis congestivo, cirrhosi, et syndrome hormonum antidiureticorum inconueniens.Tolvaptan etiam est in tentationibus ieiunii clinicis ad polycysticum morbum renum.Curatio cum Tolvaptan facit reductiones corporis celeris et sustentati ponderis cum incrementis urinae output concurrentes, meliorem et/vel normalizes serum sodium in aegros hyponatremicis, signa et indicia obstructio minuit et sitim auget.
![7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one CAS 160129-45-3](https://www.ruifuchemical.com/uploads/7-Chloro-1234-tetrahydrobenzobazepin-5-one-CAS-160129-45-3-300x300.jpg)
